DWL USA, Inc.

DWL (Compumedics Germany GmbH), operating since 1991, is a specialized manufacturer of transcranial Doppler (TCD) ultrasound systems for real-time hemodynamic monitoring and vascular diagnostics. Core products include the EZ-Dop point-of-care diagnostic system, Multi-Dop T (EU MDR 2017/745 certified), DBX/DBX1, MDX series (color Doppler and CO2 reactivity), and the MDT multi-channel monitoring platform. The company designs portable baseline systems through comprehensive multimodal solutions supporting handheld probes, micro-probes, monitoring probes, probe fixation systems, and specialized analysis software including Neuro-Monitoring-Analyse with Z-Score waveform evaluation. Clinical applications span neurology, neuro/cardiac/vascular surgery, anesthesiology, critical care, emergency medicine, ENT, and maxillofacial surgery. Primary indications include stroke management, brain death diagnosis, vasospasm detection, PFO evaluation, sickle cell disease screening, and intraoperative neuromonitoring. Systems employ fully digital Doppler sonography with M-Mode capability. DWL maintains installations in 11,000+ hospitals and clinics across 120+ countries. Manufacturing and regulatory capabilities include EU MDR compliance and ISO certification. The company provides clinical software, training support at international conferences, and technical service.